Table of Contents 1 Market Overview 1.1 Immuno-oncology Drugs Introduction 1.2 Market Analysis by Type 1.2.1 Immune Checkpoint Inhibitors 1.2.2 Monoclonal Antibodies 1.2.3 Cytokine-Based Immunotherapy 1.2.4 Cancer Vaccines 1.2.5 CAR-T Cell Therapy 1.3 Market Analysis by Applications 1.3.1 Hospitals 1.3.2 Pharmacies 1.3.3 Online Pharmacies 1.4 Market Analysis by Regions 1.4.1 North America (United States, Canada and Mexico) 1.4.1.1 United States Market States and Outlook (2013-2023) 1.4.1.2 Canada Market States and Outlook (2013-2023) 1.4.1.3 Mexico Market States and Outlook (2013-2023) 1.4.2 Europe (Germany, France, UK, Russia and Italy) 1.4.2.1 Germany Market States and Outlook (2013-2023) 1.4.2.2 France Market States and Outlook (2013-2023) 1.4.2.3 UK Market States and Outlook (2013-2023) 1.4.2.4 Russia Market States and Outlook (2013-2023) 1.4.2.5 Italy Market States and Outlook (2013-2023) 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) 1.4.3.1 China Market States and Outlook (2013-2023) 1.4.3.2 Japan Market States and Outlook (2013-2023) 1.4.3.3 Korea Market States and Outlook (2013-2023) 1.4.3.4 India Market States and Outlook (2013-2023) 1.4.3.5 Southeast Asia Market States and Outlook (2013-2023) 1.4.4 South America, Middle East and Africa 1.4.4.1 Brazil Market States and Outlook (2013-2023) 1.4.4.2 Egypt Market States and Outlook (2013-2023) 1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023) 1.4.4.4 South Africa Market States and Outlook (2013-2023) 1.4.4.5 Nigeria Market States and Outlook (2013-2023) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 2 Manufacturers Profiles 2.1 Amgen, Inc 2.1.1 Business Overview 2.1.2 Immuno-oncology Drugs Type and Applications 2.1.2.1 Product A 2.1.2.2 Product B 2.1.3 Amgen, Inc Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.2 AstraZeneca, Plc 2.2.1 Business Overview 2.2.2 Immuno-oncology Drugs Type and Applications 2.2.2.1 Product A 2.2.2.2 Product B 2.2.3 AstraZeneca, Plc Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.3 Bristol-Myers Squibb 2.3.1 Business Overview 2.3.2 Immuno-oncology Drugs Type and Applications 2.3.2.1 Product A 2.3.2.2 Product B 2.3.3 Bristol-Myers Squibb Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.4 Celgene Corporation 2.4.1 Business Overview 2.4.2 Immuno-oncology Drugs Type and Applications 2.4.2.1 Product A 2.4.2.2 Product B 2.4.3 Celgene Corporation Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.5 Eli Lilly and Company 2.5.1 Business Overview 2.5.2 Immuno-oncology Drugs Type and Applications 2.5.2.1 Product A 2.5.2.2 Product B 2.5.3 Eli Lilly and Company Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.6 Merck & Co. 2.6.1 Business Overview 2.6.2 Immuno-oncology Drugs Type and Applications 2.6.2.1 Product A 2.6.2.2 Product B 2.6.3 Merck & Co. Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.7 Hoffmann-La Roche AG 2.7.1 Business Overview 2.7.2 Immuno-oncology Drugs Type and Applications 2.7.2.1 Product A 2.7.2.2 Product B 2.7.3 Hoffmann-La Roche AG Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.8 Johnson & Johnson 2.8.1 Business Overview 2.8.2 Immuno-oncology Drugs Type and Applications 2.8.2.1 Product A 2.8.2.2 Product B 2.8.3 Johnson & Johnson Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.9 Novartis International AG 2.9.1 Business Overview 2.9.2 Immuno-oncology Drugs Type and Applications 2.9.2.1 Product A 2.9.2.2 Product B 2.9.3 Novartis International AG Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.10 AbbVie, Inc. 2.10.1 Business Overview 2.10.2 Immuno-oncology Drugs Type and Applications 2.10.2.1 Product A 2.10.2.2 Product B 2.10.3 AbbVie, Inc. Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.11 Pfizer Inc. 2.11.1 Business Overview 2.11.2 Immuno-oncology Drugs Type and Applications 2.11.2.1 Product A 2.11.2.2 Product B 2.11.3 Pfizer Inc. Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.12 Sanofi S.A. 2.12.1 Business Overview 2.12.2 Immuno-oncology Drugs Type and Applications 2.12.2.1 Product A 2.12.2.2 Product B 2.12.3 Sanofi S.A. Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.13 EMD Serono, Inc. 2.13.1 Business Overview 2.13.2 Immuno-oncology Drugs Type and Applications 2.13.2.1 Product A 2.13.2.2 Product B 2.13.3 EMD Serono, Inc. Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.14 Gilead Sciences Inc. 2.14.1 Business Overview 2.14.2 Immuno-oncology Drugs Type and Applications 2.14.2.1 Product A 2.14.2.2 Product B 2.14.3 Gilead Sciences Inc. Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.15 Prometheus Therapeutics & Diagnostics 2.15.1 Business Overview 2.15.2 Immuno-oncology Drugs Type and Applications 2.15.2.1 Product A 2.15.2.2 Product B 2.15.3 Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.16 Aduro BioTech 2.16.1 Business Overview 2.16.2 Immuno-oncology Drugs Type and Applications 2.16.2.1 Product A 2.16.2.2 Product B 2.16.3 Aduro BioTech Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.17 Galena Biopharma 2.17.1 Business Overview 2.17.2 Immuno-oncology Drugs Type and Applications 2.17.2.1 Product A 2.17.2.2 Product B 2.17.3 Galena Biopharma Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.18 Bavarian Nordic 2.18.1 Business Overview 2.18.2 Immuno-oncology Drugs Type and Applications 2.18.2.1 Product A 2.18.2.2 Product B 2.18.3 Bavarian Nordic Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.19 Celldex Therapeutics 2.19.1 Business Overview 2.19.2 Immuno-oncology Drugs Type and Applications 2.19.2.1 Product A 2.19.2.2 Product B 2.19.3 Celldex Therapeutics Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.20 ImmunoCellular Therapeutics 2.20.1 Business Overview 2.20.2 Immuno-oncology Drugs Type and Applications 2.20.2.1 Product A 2.20.2.2 Product B 2.20.3 ImmunoCellular Therapeutics Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.21 Incyte 2.21.1 Business Overview 2.2.2 Immuno-oncology Drugs Type and Applications 2.21.2.1 Product A 2.21.2.2 Product B 2.21.3 Incyte Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 3 Global Immuno-oncology Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017) 3.1 Global Immuno-oncology Drugs Sales and Market Share by Manufacturer (2016-2017) 3.2 Global Immuno-oncology Drugs Revenue and Market Share by Manufacturer (2016-2017) 3.3 Market Concentration Rate 3.3.1 Top 3 Immuno-oncology Drugs Manufacturer Market Share in 2017 3.3.2 Top 6 Immuno-oncology Drugs Manufacturer Market Share in 2017 3.4 Market Competition Trend 4 Global Immuno-oncology Drugs Market Analysis by Regions 4.1 Global Immuno-oncology Drugs Sales, Revenue and Market Share by Regions 4.1.1 Global Immuno-oncology Drugs Sales and Market Share by Regions (2013-2018) 4.1.2 Global Immuno-oncology Drugs Revenue and Market Share by Regions (2013-2018) 4.2 North America Immuno-oncology Drugs Sales and Growth Rate (2013-2018) 4.3 Europe Immuno-oncology Drugs Sales and Growth Rate (2013-2018) 4.4 Asia-Pacific Immuno-oncology Drugs Sales and Growth Rate (2013-2018) 4.5 South America Immuno-oncology Drugs Sales and Growth Rate (2013-2018) 4.6 Middle East and Africa Immuno-oncology Drugs Sales and Growth Rate (2013-2018) 5 North America Immuno-oncology Drugs by Countries 5.1 North America Immuno-oncology Drugs Sales, Revenue and Market Share by Countries 5.1.1 North America Immuno-oncology Drugs Sales and Market Share by Countries (2013-2018) 5.1.2 North America Immuno-oncology Drugs Revenue and Market Share by Countries (2013-2018) 5.2 United States Immuno-oncology Drugs Sales and Growth Rate (2013-2018) 5.3 Canada Immuno-oncology Drugs Sales and Growth Rate (2013-2018) 5.4 Mexico Immuno-oncology Drugs Sales and Growth Rate (2013-2018) 6 Europe Immuno-oncology Drugs by Countries 6.1 Europe Immuno-oncology Drugs Sales, Revenue and Market Share by Countries 6.1.1 Europe Immuno-oncology Drugs Sales and Market Share by Countries (2013-2018) 6.1.2 Europe Immuno-oncology Drugs Revenue and Market Share by Countries (2013-2018) 6.2 Germany Immuno-oncology Drugs Sales and Growth Rate (2013-2018) 6.3 UK Immuno-oncology Drugs Sales and Growth Rate (2013-2018) 6.4 France Immuno-oncology Drugs Sales and Growth Rate (2013-2018) 6.5 Russia Immuno-oncology Drugs Sales and Growth Rate (2013-2018) 6.6 Italy Immuno-oncology Drugs Sales and Growth Rate (2013-2018) 7 Asia-Pacific Immuno-oncology Drugs by Countries 7.1 Asia-Pacific Immuno-oncology Drugs Sales, Revenue and Market Share by Countries 7.1.1 Asia-Pacific Immuno-oncology Drugs Sales and Market Share by Countries (2013-2018) 7.1.2 Asia-Pacific Immuno-oncology Drugs Revenue and Market Share by Countries (2013-2018) 7.2 China Immuno-oncology Drugs Sales and Growth Rate (2013-2018) 7.3 Japan Immuno-oncology Drugs Sales and Growth Rate (2013-2018) 7.4 Korea Immuno-oncology Drugs Sales and Growth Rate (2013-2018) 7.5 India Immuno-oncology Drugs Sales and Growth Rate (2013-2018) 7.6 Southeast Asia Immuno-oncology Drugs Sales and Growth Rate (2013-2018) 8 South America Immuno-oncology Drugs by Countries 8.1 South America Immuno-oncology Drugs Sales, Revenue and Market Share by Countries 8.1.1 South America Immuno-oncology Drugs Sales and Market Share by Countries (2013-2018) 8.1.2 South America Immuno-oncology Drugs Revenue and Market Share by Countries (2013-2018) 8.2 Brazil Immuno-oncology Drugs Sales and Growth Rate (2013-2018) 8.3 Argentina Immuno-oncology Drugs Sales and Growth Rate (2013-2018) 8.4 Colombia Immuno-oncology Drugs Sales and Growth Rate (2013-2018) 9 Middle East and Africa Immuno-oncology Drugs by Countries 9.1 Middle East and Africa Immuno-oncology Drugs Sales, Revenue and Market Share by Countries 9.1.1 Middle East and Africa Immuno-oncology Drugs Sales and Market Share by Countries (2013-2018) 9.1.2 Middle East and Africa Immuno-oncology Drugs Revenue and Market Share by Countries (2013-2018) 9.2 Saudi Arabia Immuno-oncology Drugs Sales and Growth Rate (2013-2018) 9.3 UAE Immuno-oncology Drugs Sales and Growth Rate (2013-2018) 9.4 Egypt Immuno-oncology Drugs Sales and Growth Rate (2013-2018) 9.5 Nigeria Immuno-oncology Drugs Sales and Growth Rate (2013-2018) 9.6 South Africa Immuno-oncology Drugs Sales and Growth Rate (2013-2018) 10 Global Immuno-oncology Drugs Market Segment by Type 10.1 Global Immuno-oncology Drugs Sales, Revenue and Market Share by Type (2013-2018) 10.1.1 Global Immuno-oncology Drugs Sales and Market Share by Type (2013-2018) 10.1.2 Global Immuno-oncology Drugs Revenue and Market Share by Type (2013-2018) 10.2 Immune Checkpoint Inhibitors Sales Growth and Price 10.2.1 Global Immune Checkpoint Inhibitors Sales Growth (2013-2018) 10.2.2 Global Immune Checkpoint Inhibitors Price (2013-2018) 10.3 Monoclonal Antibodies Sales Growth and Price 10.3.1 Global Monoclonal Antibodies Sales Growth (2013-2018) 10.3.2 Global Monoclonal Antibodies Price (2013-2018) 10.4 Cytokine-Based Immunotherapy Sales Growth and Price 10.4.1 Global Cytokine-Based Immunotherapy Sales Growth (2013-2018) 10.4.2 Global Cytokine-Based Immunotherapy Price (2013-2018) 10.5 Cancer Vaccines Sales Growth and Price 10.5.1 Global Cancer Vaccines Sales Growth (2013-2018) 10.5.2 Global Cancer Vaccines Price (2013-2018) 10.6 CAR-T Cell Therapy Sales Growth and Price 10.6.1 Global CAR-T Cell Therapy Sales Growth (2013-2018) 10.6.2 Global CAR-T Cell Therapy Price (2013-2018) 11 Global Immuno-oncology Drugs Market Segment by Application 11.1 Global Immuno-oncology Drugs Sales Market Share by Application (2013-2018) 11.2 Hospitals Sales Growth (2013-2018) 11.3 Pharmacies Sales Growth (2013-2018) 11.4 Online Pharmacies Sales Growth (2013-2018) 12 Immuno-oncology Drugs Market Forecast (2018-2023) 12.1 Global Immuno-oncology Drugs Sales, Revenue and Growth Rate (2018-2023) 12.2 Immuno-oncology Drugs Market Forecast by Regions (2018-2023) 12.2.1 North America Immuno-oncology Drugs Market Forecast (2018-2023) 12.2.2 Europe Immuno-oncology Drugs Market Forecast (2018-2023) 12.2.3 Asia-Pacific Immuno-oncology Drugs Market Forecast (2018-2023) 12.2.4 South America Immuno-oncology Drugs Market Forecast (2018-2023) 12.2.5 Middle East and Africa Immuno-oncology Drugs Market Forecast (2018-2023) 12.3 Immuno-oncology Drugs Market Forecast by Type (2018-2023) 12.3.1 Global Immuno-oncology Drugs Sales Forecast by Type (2018-2023) 12.3.2 Global Immuno-oncology Drugs Market Share Forecast by Type (2018-2023) 12.4 Immuno-oncology Drugs Market Forecast by Application (2018-2023) 12.4.1 Global Immuno-oncology Drugs Sales Forecast by Application (2018-2023) 12.4.2 Global Immuno-oncology Drugs Market Share Forecast by Application (2018-2023) 13 Sales Channel, Distributors, Traders and Dealers 13.1 Sales Channel 13.1.1 Direct Marketing 13.1.2 Indirect Marketing 13.1.3 Marketing Channel Future Trend 13.2 Distributors, Traders and Dealers 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology 15.2 Data Source

List of Tables and Figures Figure Immuno-oncology Drugs Picture Table Product Specifications of Immuno-oncology Drugs Figure Global Sales Market Share of Immuno-oncology Drugs by Types in 2017 Table Immuno-oncology Drugs Types for Major Manufacturers Figure Immune Checkpoint Inhibitors Picture Figure Monoclonal Antibodies Picture Figure Cytokine-Based Immunotherapy Picture Figure Cancer Vaccines Picture Figure CAR-T Cell Therapy Picture Figure Immuno-oncology Drugs Sales Market Share by Applications in 2017 Figure Hospitals Picture Figure Pharmacies Picture Figure Online Pharmacies Picture Figure United States Immuno-oncology Drugs Revenue (Value) and Growth Rate (2013-2023) Figure Canada Immuno-oncology Drugs Revenue (Value) and Growth Rate (2013-2023) Figure Mexico Immuno-oncology Drugs Revenue (Value) and Growth Rate (2013-2023) Figure Germany Immuno-oncology Drugs Revenue (Value) and Growth Rate (2013-2023) Figure France Immuno-oncology Drugs Revenue (Value) and Growth Rate (2013-2023) Figure UK Immuno-oncology Drugs Revenue (Value) and Growth Rate (2013-2023) Figure Russia Immuno-oncology Drugs Revenue (Value) and Growth Rate (2013-2023) Figure Italy Immuno-oncology Drugs Revenue (Value) and Growth Rate (2013-2023) Figure China Immuno-oncology Drugs Revenue (Value) and Growth Rate (2013-2023) Figure Japan Immuno-oncology Drugs Revenue (Value) and Growth Rate (2013-2023) Figure Korea Immuno-oncology Drugs Revenue (Value) and Growth Rate (2013-2023) Figure India Immuno-oncology Drugs Revenue (Value) and Growth Rate (2013-2023) Figure Southeast Asia Immuno-oncology Drugs Revenue (Value) and Growth Rate (2013-2023) Figure Brazil Immuno-oncology Drugs Revenue (Value) and Growth Rate (2013-2023) Figure Egypt Immuno-oncology Drugs Revenue (Value) and Growth Rate (2013-2023) Figure Saudi Arabia Immuno-oncology Drugs Revenue (Value) and Growth Rate (2013-2023) Figure South Africa Immuno-oncology Drugs Revenue (Value) and Growth Rate (2013-2023) Figure Nigeria Immuno-oncology Drugs Revenue (Value) and Growth Rate (2013-2023) Table Amgen, Inc Basic Information, Manufacturing Base and Competitors Table Amgen, Inc Immuno-oncology Drugs Type and Applications Table Amgen, Inc Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table AstraZeneca, Plc Basic Information, Manufacturing Base and Competitors Table AstraZeneca, Plc Immuno-oncology Drugs Type and Applications Table AstraZeneca, Plc Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors Table Bristol-Myers Squibb Immuno-oncology Drugs Type and Applications Table Bristol-Myers Squibb Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Celgene Corporation Basic Information, Manufacturing Base and Competitors Table Celgene Corporation Immuno-oncology Drugs Type and Applications Table Celgene Corporation Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Eli Lilly and Company Basic Information, Manufacturing Base and Competitors Table Eli Lilly and Company Immuno-oncology Drugs Type and Applications Table Eli Lilly and Company Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Merck & Co. Basic Information, Manufacturing Base and Competitors Table Merck & Co. Immuno-oncology Drugs Type and Applications Table Merck & Co. Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Hoffmann-La Roche AG Basic Information, Manufacturing Base and Competitors Table Hoffmann-La Roche AG Immuno-oncology Drugs Type and Applications Table Hoffmann-La Roche AG Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors Table Johnson & Johnson Immuno-oncology Drugs Type and Applications Table Johnson & Johnson Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Novartis International AG Basic Information, Manufacturing Base and Competitors Table Novartis International AG Immuno-oncology Drugs Type and Applications Table Novartis International AG Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table AbbVie, Inc. Basic Information, Manufacturing Base and Competitors Table AbbVie, Inc. Immuno-oncology Drugs Type and Applications Table AbbVie, Inc. Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Pfizer Inc. Basic Information, Manufacturing Base and Competitors Table Pfizer Inc. Immuno-oncology Drugs Type and Applications Table Pfizer Inc. Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Sanofi S.A. Basic Information, Manufacturing Base and Competitors Table Sanofi S.A. Immuno-oncology Drugs Type and Applications Table Sanofi S.A. Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table EMD Serono, Inc. Basic Information, Manufacturing Base and Competitors Table EMD Serono, Inc. Immuno-oncology Drugs Type and Applications Table EMD Serono, Inc. Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Gilead Sciences Inc. Basic Information, Manufacturing Base and Competitors Table Gilead Sciences Inc. Immuno-oncology Drugs Type and Applications Table Gilead Sciences Inc. Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Prometheus Therapeutics & Diagnostics Basic Information, Manufacturing Base and Competitors Table Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs Type and Applications Table Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Aduro BioTech Basic Information, Manufacturing Base and Competitors Table Aduro BioTech Immuno-oncology Drugs Type and Applications Table Aduro BioTech Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Galena Biopharma Basic Information, Manufacturing Base and Competitors Table Galena Biopharma Immuno-oncology Drugs Type and Applications Table Galena Biopharma Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Bavarian Nordic Basic Information, Manufacturing Base and Competitors Table Bavarian Nordic Immuno-oncology Drugs Type and Applications Table Bavarian Nordic Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Celldex Therapeutics Basic Information, Manufacturing Base and Competitors Table Celldex Therapeutics Immuno-oncology Drugs Type and Applications Table Celldex Therapeutics Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table ImmunoCellular Therapeutics Basic Information, Manufacturing Base and Competitors Table ImmunoCellular Therapeutics Immuno-oncology Drugs Type and Applications Table ImmunoCellular Therapeutics Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Incyte Basic Information, Manufacturing Base and Competitors Table Incyte Immuno-oncology Drugs Type and Applications Table Incyte Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Global Immuno-oncology Drugs Sales by Manufacturer (2016-2017) Figure Global Immuno-oncology Drugs Sales Market Share by Manufacturer in 2016 Figure Global Immuno-oncology Drugs Sales Market Share by Manufacturer in 2017 Table Global Immuno-oncology Drugs Revenue by Manufacturer (2016-2017) Figure Global Immuno-oncology Drugs Revenue Market Share by Manufacturer in 2016 Figure Global Immuno-oncology Drugs Revenue Market Share by Manufacturer in 2017 Figure Top 3 Immuno-oncology Drugs Manufacturer (Revenue) Market Share in 2017 Figure Top 6 Immuno-oncology Drugs Manufacturer (Revenue) Market Share in 2017 Figure Global Immuno-oncology Drugs Sales and Growth Rate (2013-2018) Figure Global Immuno-oncology Drugs Revenue and Growth Rate (2013-2018) Table Global Immuno-oncology Drugs Sales by Regions (2013-2018) Table Global Immuno-oncology Drugs Sales Market Share by Regions (2013-2018) Table Global Immuno-oncology Drugs Revenue by Regions (2013-2018) Figure Global Immuno-oncology Drugs Revenue Market Share by Regions in 2013 Figure Global Immuno-oncology Drugs Revenue Market Share by Regions in 2017 Figure North America Immuno-oncology Drugs Sales and Growth Rate (2013-2018) Figure Europe Immuno-oncology Drugs Sales and Growth Rate (2013-2018) Figure Asia-Pacific Immuno-oncology Drugs Sales and Growth Rate (2013-2018) Figure South America Immuno-oncology Drugs Sales and Growth Rate (2013-2018) Figure Middle East and Africa Immuno-oncology Drugs Sales and Growth Rate (2013-2018) Figure North America Immuno-oncology Drugs Revenue and Growth Rate (2013-2018) Table North America Immuno-oncology Drugs Sales by Countries (2013-2018) Table North America Immuno-oncology Drugs Sales Market Share by Countries (2013-2018) Figure North America Immuno-oncology Drugs Sales Market Share by Countries in 2013 Figure North America Immuno-oncology Drugs Sales Market Share by Countries in 2017 Table North America Immuno-oncology Drugs Revenue by Countries (2013-2018) Table North America Immuno-oncology Drugs Revenue Market Share by Countries (2013-2018) Figure North America Immuno-oncology Drugs Revenue Market Share by Countries in 2013 Figure North America Immuno-oncology Drugs Revenue Market Share by Countries in 2017 Figure United States Immuno-oncology Drugs Sales and Growth Rate (2013-2018) Figure Canada Immuno-oncology Drugs Sales and Growth Rate (2013-2018) Figure Mexico Immuno-oncology Drugs Sales and Growth Rate (2013-2018) Figure Europe Immuno-oncology Drugs Revenue and Growth Rate (2013-2018) Table Europe Immuno-oncology Drugs Sales by Countries (2013-2018) Table Europe Immuno-oncology Drugs Sales Market Share by Countries (2013-2018) Table Europe Immuno-oncology Drugs Revenue by Countries (2013-2018) Figure Europe Immuno-oncology Drugs Revenue Market Share by Countries in 2016 Figure Europe Immuno-oncology Drugs Revenue Market Share by Countries in 2017 Figure Germany Immuno-oncology Drugs Sales and Growth Rate (2013-2018) Figure UK Immuno-oncology Drugs Sales and Growth Rate (2013-2018) Figure France Immuno-oncology Drugs Sales and Growth Rate (2013-2018) Figure Russia Immuno-oncology Drugs Sales and Growth Rate (2013-2018) Figure Italy Immuno-oncology Drugs Sales and Growth Rate (2013-2018) Figure Asia-Pacific Immuno-oncology Drugs Revenue and Growth Rate (2013-2018) Table Asia-Pacific Immuno-oncology Drugs Sales by Countries (2013-2018) Table Asia-Pacific Immuno-oncology Drugs Sales Market Share by Countries (2013-2018) Figure Asia-Pacific Immuno-oncology Drugs Sales Market Share by Countries 2017 Table Asia-Pacific Immuno-oncology Drugs Revenue by Countries (2013-2018) Figure Asia-Pacific Immuno-oncology Drugs Revenue Market Share by Countries 2017 Figure China Immuno-oncology Drugs Sales and Growth Rate (2013-2018) Figure Japan Immuno-oncology Drugs Sales and Growth Rate (2013-2018) Figure Korea Immuno-oncology Drugs Sales and Growth Rate (2013-2018) Figure India Immuno-oncology Drugs Sales and Growth Rate (2013-2018) Figure Southeast Asia Immuno-oncology Drugs Sales and Growth Rate (2013-2018) Figure South America Immuno-oncology Drugs Revenue and Growth Rate (2013-2018) Table South America Immuno-oncology Drugs Sales by Countries (2013-2018) Table South America Immuno-oncology Drugs Sales Market Share by Countries (2013-2018) Figure South America Immuno-oncology Drugs Sales Market Share by Countries in 2017 Table South America Immuno-oncology Drugs Revenue by Countries (2013-2018) Table South America Immuno-oncology Drugs Revenue Market Share by Countries (2013-2018) Figure South America Immuno-oncology Drugs Revenue Market Share by Countries in 2017 Figure Brazil Immuno-oncology Drugs Sales and Growth Rate (2013-2018) Figure Argentina Immuno-oncology Drugs Sales and Growth Rate (2013-2018) Figure Colombia Immuno-oncology Drugs Sales and Growth Rate (2013-2018) Figure Middle East and Africa Immuno-oncology Drugs Revenue and Growth Rate (2013-2018) Table Middle East and Africa Immuno-oncology Drugs Sales by Countries (2013-2018) Table Middle East and Africa Immuno-oncology Drugs Sales Market Share by Countries (2013-2018) Figure Middle East and Africa Immuno-oncology Drugs Sales Market Share by Countries in 2017 Table Middle East and Africa Immuno-oncology Drugs Revenue by Countries (2013-2018) Table Middle East and Africa Immuno-oncology Drugs Revenue Market Share by Countries (2013-2018) Figure Middle East and Africa Immuno-oncology Drugs Revenue Market Share by Countries in 2013 Figure Middle East and Africa Immuno-oncology Drugs Revenue Market Share by Countries in 2017 Figure Saudi Arabia Immuno-oncology Drugs Sales and Growth Rate (2013-2018) Figure UAE Immuno-oncology Drugs Sales and Growth Rate (2013-2018) Figure Egypt Immuno-oncology Drugs Sales and Growth Rate (2013-2018) Figure Nigeria Immuno-oncology Drugs Sales and Growth Rate (2013-2018) Figure South Africa Immuno-oncology Drugs Sales and Growth Rate (2013-2018) Table Global Immuno-oncology Drugs Sales by Type (2013-2018) Table Global Immuno-oncology Drugs Sales Share by Type (2013-2018) Table Global Immuno-oncology Drugs Revenue by Type (2013-2018) Table Global Immuno-oncology Drugs Revenue Share by Type (2013-2018) Figure Global Immune Checkpoint Inhibitors Sales Growth (2013-2018) Figure Global Immune Checkpoint Inhibitors Price (2013-2018) Figure Global Monoclonal Antibodies Sales Growth (2013-2018) Figure Global Monoclonal Antibodies Price (2013-2018) Figure Global Cytokine-Based Immunotherapy Sales Growth (2013-2018) Figure Global Cytokine-Based Immunotherapy Price (2013-2018) Figure Global Cancer Vaccines Sales Growth (2013-2018) Figure Global Cancer Vaccines Price (2013-2018) Figure Global CAR-T Cell Therapy Sales Growth (2013-2018) Figure Global CAR-T Cell Therapy Price (2013-2018) Table Global Immuno-oncology Drugs Sales by Application (2013-2018) Table Global Immuno-oncology Drugs Sales Share by Application (2013-2018) Figure Global Pharmacies Sales Growth (2013-2018) Figure Global Online Pharmacies Sales Growth (2013-2018) Figure Global Immuno-oncology Drugs Sales, Revenue and Growth Rate (2018-2023) Table Global Immuno-oncology Drugs Sales Forecast by Regions (2018-2023) Table Global Immuno-oncology Drugs Market Share Forecast by Regions (2018-2023) Figure North America Sales Immuno-oncology Drugs Market Forecast (2018-2023) Figure Europe Sales Immuno-oncology Drugs Market Forecast (2018-2023) Figure Asia-Pacific Sales Immuno-oncology Drugs Market Forecast (2018-2023) Figure South America Sales Immuno-oncology Drugs Market Forecast (2018-2023) Figure Middle East and Africa Sales Immuno-oncology Drugs Market Forecast (2018-2023) Table Global Immuno-oncology Drugs Sales Forecast by Type (2018-2023) Table Global Immuno-oncology Drugs Market Share Forecast by Type (2018-2023) Table Global Immuno-oncology Drugs Sales Forecast by Application (2018-2023) Table Global Immuno-oncology Drugs Market Share Forecast by Application (2018-2023) Table Distributors/Traders/ Dealers List

Amgen, Inc AstraZeneca, Plc Bristol-Myers Squibb Celgene Corporation Eli Lilly and Company Merck & Co. Hoffmann-La Roche AG Johnson & Johnson Novartis International AG AbbVie, Inc. Pfizer Inc. Sanofi S.A. EMD Serono, Inc. Gilead Sciences Inc. Prometheus Therapeutics & Diagnostics Aduro BioTech Galena Biopharma Bavarian Nordic Celldex Therapeutics ImmunoCellular Therapeutics Incyte